These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2844110)

  • 41. Oral etoposide in germ cell tumours.
    Saxman S
    Drugs; 1999; 58 Suppl 3():31-4. PubMed ID: 10711839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclophosphamide and etoposide for non-small cell and small cell lung cancer.
    Grunberg SM
    Drugs; 1999; 58 Suppl 3():11-5. PubMed ID: 10711836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effects on sexual function and fertility after treatment of testicular cancer.
    Hartmann JT; Albrecht C; Schmoll HJ; Kuczyk MA; Kollmannsberger C; Bokemeyer C
    Br J Cancer; 1999 May; 80(5-6):801-7. PubMed ID: 10360658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro drug sensitivity testing of human testicular germ cell tumours with cytostatic drugs and interferon alpha-2b.
    Küpeli B; Baltaci S; Beksac M; Süzer O; Küpeli S; Göğüs O
    Int Urol Nephrol; 1997; 29(1):79-84. PubMed ID: 9203042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
    Barnett MJ; Coppin CM; Murray N; Nevill TJ; Reece DE; Klingemann HG; Shepherd JD; Nantel SH; Sutherland HJ; Phillips GL
    Br J Cancer; 1993 Sep; 68(3):594-8. PubMed ID: 8394733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etoposide: current status and future perspectives in the management of malignant neoplasms.
    Belani CP; Doyle LA; Aisner J
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S118-26. PubMed ID: 8070020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I study of high-dose cisplatin, ifosfamide, and etoposide.
    Perez EA; Sowray PC; Gardner SL; Gandara DR
    Cancer Chemother Pharmacol; 1994; 34(4):331-4. PubMed ID: 8033300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment intensification in disseminated germ-cell tumors.
    Beyer J; Bokemeyer C; Schmoll HJ; Siegert W
    World J Urol; 1994; 12(4):207-13. PubMed ID: 7820143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymomas. Current experience and future directions in therapy.
    Loehrer PJ
    Drugs; 1993 Apr; 45(4):477-87. PubMed ID: 7684669
    [No Abstract]   [Full Text] [Related]  

  • 51. Prognosis after salvage treatment for unselected male patients with germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Hartenstein R; Lamerz R; Wilmanns W
    Br J Cancer; 1995 Oct; 72(4):1026-32. PubMed ID: 7547217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.
    Henwood JM; Brogden RN
    Drugs; 1990 Mar; 39(3):438-90. PubMed ID: 2184009
    [No Abstract]   [Full Text] [Related]  

  • 53. Dosing and side-effects of ifosfamide plus mesna.
    Brade WP; Herdrich K; Kachel-Fischer U; Araujo CE
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S164-86. PubMed ID: 1795007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal drug therapy in the treatment of testicular cancer.
    Priest ER; Vogelzang NJ
    Drugs; 1991 Jul; 42(1):52-64. PubMed ID: 1718685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cisplatin.
    Haim N; Rosenblatt E; Wollner M; Ben-Shahar M; Epelbaum R; Robinson E
    Cancer Chemother Pharmacol; 1992; 30(3):243-4. PubMed ID: 1628376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
    Loehrer PJ; Lauer R; Roth BJ; Williams SD; Kalasinski LA; Einhorn LH
    Ann Intern Med; 1988 Oct; 109(7):540-6. PubMed ID: 2844110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
    Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
    Motzer RJ; Cooper K; Geller NL; Bajorin DF; Dmitrovsky E; Herr H; Morse M; Fair W; Sogani P; Russo P
    Cancer; 1990 Dec; 66(12):2476-81. PubMed ID: 2174300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
    Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
    Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ifosfamide in testicular cancer.
    Loehrer PJ
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):2-5. PubMed ID: 2159186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.